ALKS vs ILMN · P/E 14, rev $1.56B vs rev $4.34B
Alkermes Plc (ALKS) versus Illumina Inc (ILMN) — a side-by-side from cached financials, not a winner call.
Alkermes Plc (ALKS) is a drug manufacturers - specialty & generic company listed on US.
Illumina Inc (ILMN) is a diagnostics & research company listed on US.
Latest reported ALKS revenue for 2024-12-31 was $1.56B. Net income was $367.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. ALKS currently screens at market cap $4.78B and trailing P/E 13.8.
Latest reported ILMN revenue for 2025-12-28 was $4.34B. Net income was $850.0M. Revenue was down 0.7% from 2024-12-29 to 2025-12-28. ILMN currently screens at market cap $15.84B.
ALKS currently screens at market cap $4.78B and trailing P/E 13.8. ILMN currently screens at market cap $15.84B.
Not investment advice. Open the ALKS and ILMN stock pages for the full models.
Not investment advice.